These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21261126)

  • 1. Informed consent elements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Jan; 76(2):256-70. PubMed ID: 21261126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of human subjects; informed consent--FDA. Final rule.
    Fed Regist; 1996 Oct; 61(192):51498-533. PubMed ID: 10161558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Trials Registration and Results Information Submission. Final rule.
    National Institutes of Health, Department of Health and Human Services
    Fed Regist; 2016 Sep; 81(183):64981-5157. PubMed ID: 27658315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of human subjects; informed consent--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(17 pt 2):8942-58. PubMed ID: 10249528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA's emergency research rule: an inch given, a yard taken.
    Gillenwater GE
    Food Drug Law J; 2008; 63(1):217-56. PubMed ID: 18561460
    [No Abstract]   [Full Text] [Related]  

  • 6. Human drugs and biologics; determination that informed consent is NOT feasible or is contrary to the best interests of recipients; revocation of 1990 interim final rule; establishment of new interim final rule. Food and Drug Administration, HHS. Interim final rule; opportunity for public comment.
    Fed Regist; 1999 Oct; 64(192):54180-9. PubMed ID: 11010702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational new drug application; exception from informed consent; technical amendment--FDA. Final rule.
    Fed Regist; 1997 Jun; 62(115):32479. PubMed ID: 10169828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of human subjects; informed consent; correction. Food and Drug Administration. Final rule; correction.
    Fed Regist; 1982 Feb; 47(31):6617-8. PubMed ID: 10298463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory and ethical considerations for linking clinical and administrative databases.
    Dokholyan RS; Muhlbaier LH; Falletta JM; Jacobs JP; Shahian D; Haan CK; Peterson ED
    Am Heart J; 2009 Jun; 157(6):971-82. PubMed ID: 19464406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplemental standards of ethical conduct and financial disclosure requirements for employees of the Department of Health and Human Services. Interim final rule with request for comments.
    Department of Health and Human Services (HHS)
    Fed Regist; 2005 Feb; 70(22):5543-65. PubMed ID: 15690579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protecting research subjects--what must be done.
    Shalala D
    N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA given new powers over data reporting to national clinical trials registry.
    Roehr B
    BMJ; 2012 Oct; 345():e6629. PubMed ID: 23033375
    [No Abstract]   [Full Text] [Related]  

  • 13. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
    Vanderpool HY
    Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulations concerning data transparency- a comparison between the USA and Europe].
    Quack C
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(3):183-8. PubMed ID: 21530907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Final rule.
    Fed Regist; 1991 Jun; 56(117):28025-9. PubMed ID: 10112215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light, fast, and flexible: a new approach to regulation of human gene therapy.
    Cregan JA
    McGeorge Law Rev; 2000; 32(1):261-87. PubMed ID: 15709266
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical devices; exception from general requirements for informed consent. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Jun; 76(122):36989-93. PubMed ID: 21736160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare's revised clinical trial policy and clinical trial-related provisions of FDAAA: what is a sponsor to do?
    Dobbins K; Scanlan K
    Food Drug Law J; 2007; 62(4):695-708. PubMed ID: 18557226
    [No Abstract]   [Full Text] [Related]  

  • 19. Transparency for clinical trials--the TEST Act.
    Drazen JM
    N Engl J Med; 2012 Aug; 367(9):863-4. PubMed ID: 22873430
    [No Abstract]   [Full Text] [Related]  

  • 20. Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov.
    Law MR; Kawasumi Y; Morgan SG
    Health Aff (Millwood); 2011 Dec; 30(12):2338-45. PubMed ID: 22147862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.